I was reading this article then this caught my att
Post# of 72430
Eli Lilly offers $400M-plus deal to bag an early-stage autoimmune drug from Nektar
Quote:
With little more than preclinical data and some initial dosing cohort insights available for review, Eli Lilly is making a $400 million-plus play to buy into an early-stage autoimmune drug at Nektar $NKTR that the pharma giant believes has megablockbuster potential.
Eli Lilly $LLY has agreed to acquire co-development rights on NKTR-358 — which was first dosed in a human in a Phase I study 4 months ago — for $150 million up front plus $250 million in milestones. Lilly will pick up 75% of the Phase II development costs and Nektar will have the opt-in rights on this drug on an indication-by-indication basis.
https://endpts.com/eli-lilly-buys-into-a-400m...om-nektar/
So $150M upfront payment for a Phase 1 drug with the potential to treat different autoimmune diseases. If only IPIX has a similar drug...
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
![Dont-give-up.jpg](https://styleshack.com/wp-content/uploads/2014/07/Dont-give-up.jpg)